Medical journals and pharmaceutical companies: Uneasy bedfellows;Revistas especializadas y empresas farmacéuticas: Una alianza incómoda

Revista de Neurologia

Volumn 38, Issue 1, 2004, Pages 3-6

  Smith, Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENOXAPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACCURACY; ADVERTIZING; CLINICAL RESEARCH; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; DRUG USE; EDITORIAL; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; OUTCOMES RESEARCH; PUBLICATION; RESPONSIBILITY;

EID: 1342321665     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3801.2003337     Document Type: Editorial

References (8)

1. Gottlieb S. Congress criticises drugs industry for misleading advertising. BMJ 2002; 325: 137.
2. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992; 116: 912-9.
3. Villanueva P, Peiro S, Librero J, Pereiro I. Accuracy of pharmaceutical advertisements in medical journals. Lancet. 2003; 361: 27-32.
4. Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, et al. A study of manufacturer supported trials of non-steroidical anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994; 154: 157-63.
5. Egger M, Bartlett C, Jüny P. Are randomised controlled trials in the BMJ different? BMJ 2001; 323: 1253.
6. Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, et al. Sponsorship, authorship, and accountability. Lancet 2001; 358: 854-6.
7. Rochon PA, Gurwitz JH, Cheung M, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994; 272: 108-13.
8. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996; 124: 485-9.